全球阿片类药物市场规模研究和预测：按产品类型（美沙酮,可待因,芬太尼,羟考酮,吗啡,氢可酮）,应用（疼痛管理,咳嗽/腹泻治疗）区域分析2022-2029

2021 年全球阿片类药物市场价值约为 226.6 亿美元，预计在 2022-2029 年预测期内将以超过 1.2% 的健康增长率增长。

阿片类药物是通过作用于阿片受体发挥吗啡作用的医疗药物，用于包括麻醉在内的镇痛□□。 市场增长是由这些因素推动的，再加上人口中慢性疼痛发病率的增加、这些药物的消费量增加以对抗疼痛以及老年人口的增加。

产品批准数量的增加和用于治疗慢性疼痛患者的新型阿片类药物的推出正在促进市场增长。 例如，2020 年 8 月，FDA（食品药品监督管理局）批准了 Trevena 开发的奥林匹克（Olycerin）注射液。 这种新型注射剂专为治疗成人急性疼痛而开发，每 10 毫升的成本约为 194 美元。 因此，阿片类药物相关疗法的监管批准和推出正在对全球市场增长产生积极影响。 此外，研发活动投资的增加和医疗费用的上涨在预测期内提供了各种有利可图的机会。 然而，对阿片类药物处方实施严格的政府法规和增加阿片类药物成瘾（阿片类药物危机）限制了整个 2022-2029 年预测期内的市场增长。

全球阿片类药物市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于基于阿片类药物的批准增加以及未满足的医疗需求，北美在收入方面占据了市场主导地位。 另一方面，由于政府举措的增加以及对提供用于疼痛管理的高质量阿片类药物的更加关注等因素，预计亚太地区在预测期内将以最高的复合年增长率增长。

本研究的目的是阐明近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 该报告旨在包括被调查国家工业的定性和定量方面。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的微观市场潜在机会，以及对主要参与者的竞争格局和产品供应的深入分析。

内容

第 1 章执行摘要

• 市场概况
• 2019-2029 年各细分市场的全球市场估计和预测
  • 阿片类药物市场：地区，2019-2029
  • 阿片类药物市场：按产品类型分类，2019-2029 年
  • 阿片类药物市场，按应用，2019-2029
• 主要趋势
• 调查方法
• 调查先决条件

第 2 章。全球阿片类药物市场的定义和范围

• 调查的目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 调查年份
• 货币兑换率

第 3 章全球阿片类药物市场动态

• 阿片类药物市场影响分析 (2019-2029)
  • 市场驱动力
    • 新阿片类药物的产品批准数量和引进数量增加
    • 人群中慢性疼痛的发病率增加
  • 市场挑战
    • 对阿片类药物处方执行严格的政府法规
    • 阿片类药物成瘾率上升（阿片类药物危机）
  • 市场机会
    • 增加研发投资
    • 医疗费用增加

第 4 章全球阿片类药物市场行业分析

• 波特 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 波特 5 力模型的未来方法 (2019-2029)
• 害虫分析
  • 政治
  • 经济的
  • 社交
  • 技术
• 顶级投资机会
• 关键成功策略
• 行业专家的展望
• 分析师的结论和建议

第 5 章风险评估：COVID-19 的影响

• 评估 COVID-19 对行业的总体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球阿片类药物市场：按产品类型分类

• 市场概况
• 阿片类药物的全球市场：按产品类型分类的性能潜力分析
• 2019-2029 年全球阿片类药物市场、按产品类型估算和预测
• 全球阿片类药物市场，按细分市场分析
  • 美沙酮
  • 可待因
  • 芬太尼
  • 羟考酮
  • 吗啡
  • 氢可酮
  • 其他

第 7 章。全球阿片类药物市场：按应用

• 市场概况
• 阿片类药物的全球市场：按应用分类的性能潜力分析
• 世界阿片类药物市场、按应用估算和预测（2019 年至 2029 年）
• 全球阿片类药物市场细分分析
  • 疼痛管理
  • 止咳药
  • 腹泻治疗

第 8 章阿片类药物的全球市场：区域分析

• 阿片类药物全球市场、区域市场概况
• 北美
  • 美国
    • 按产品类型估算和预测，2019 年至 2029 年
    • 按应用分类的估计和预测，2019-2029 年
  • 加拿大
• 欧洲阿片类药物市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲地区
• 亚太地区阿片类药物市场概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲阿片类药物市场概况
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地区
• 世界其他地方

第 9 章衝突信息

• 顶级市场策略
• 公司简介
  • 梯瓦製药工业有限公司
    • 主要信息
    • 概览
    • 财务信息（取决于数据可用性）
    • 产品概述
    • 近期趋势
  • Purdue Pharma LP
  • AstraZeneca Plc
  • C.H. Boehringer Sohn Ag and Co. Kg
  • Johnson & Johnson, Inc.
  • Sanofi S.A.
  • Mallinckrodt Pharmaceuticals
  • Endo Pharmaceuticals Inc.
  • Pfizer, Inc.
  • Sun Pharmaceuticals Industries Limited

第 10 章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场评估
  • 验证
  • 出版
• 调查属性
• 调查先决条件

Global Opioids Market is valued at approximately USD 22.66 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 1.2% over the forecast period 2022-2029. Opioids are medical agents that act on opioid receptors to cause morphine effects, which are used for pain relief, including anaesthesia. The market growth is driven by the factors such as increasing incidences of chronic pain among the population, a rise in consumption of these drugs to combat pain, coupled with the escalating geriatric population.

The rising number of product approval and the introduction of novel opioid medicines to cure patients suffering from chronic pain are acting as catalyzing factors for the growth of the market. For instance, in August 2020, Olinvyk (oliceridine) injection developed by Trevena, Inc., received Food and Drug Administration (FDA) approval. This new injection is developed to treat adults with acute pain that costs around USD 194 for a supply of 10 ml. Thereby, the rising launch of opioids-associated therapeutics with regulatory approvals is exhibiting a positive influence on market growth across the world. Moreover, growing investments in R&D activities, as well as the increasing healthcare expenditure are presenting various lucrative opportunities over the forecasting years. However, the execution of stringent government regulations for opioid prescription and the rise in opioid addiction (opioid crisis) is restricting the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Opioids Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising increasing approval of opioid-based medicines, along with the unmet medical needs. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing number of initiatives undertaken by the government, as well as rising focus on providing high-quality opioids intended for pain management in the market space.

Major market players included in this report are:

Teva Pharmaceutical Industries Limited

Purdue Pharma LP

AstraZeneca Plc

C.H. Boehringer Sohn Ag and Co. Kg

Johnson & Johnson, Inc.

Sanofi S.A.

Mallinckrodt Pharmaceuticals

Endo Pharmaceuticals Inc.

Pfizer, Inc.

Sun Pharmaceuticals Industries Limited

Recent Developments in the Market:

• In August 2022, Adalvo announced the acquisition of Onsolis a branded opioid product from a reputed U.S.-based specialty pharmacy company. The product is specially designed to indicate the management of chronic pain in cancer. The objective of this acquisition is to expand the company's opioid product portfolio and present a high-growth opportunity for the company.

Global Opioids Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Product Type, Application, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Methadone

Codeine

Fentanyl

Oxycodone

Morphine

Hydrocodone

Others

By Application:

Pain Management

Cough Treatment

Diarrhea Treatment

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Opioids Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Opioids Market, by Product Type, 2019-2029 (USD Billion)
  • 1.2.3. Opioids Market, by Application, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Opioids Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Opioids Market Dynamics

• 3.1. Opioids Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising number of product approval and the introduction of novel opioid medicines
    • 3.1.1.2. Increasing incidences of chronic pains among the population
  • 3.1.2. Market Challenges
    • 3.1.2.1. Execution of stringent government regulations for opioid prescription
    • 3.1.2.2. Rise in opioid addiction (opioid crisis)
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing investments in R&D activities
    • 3.1.3.2. Increasing healthcare expenditure

Chapter 4. Global Opioids Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Opioids Market, by Product Type

• 6.1. Market Snapshot
• 6.2. Global Opioids Market by Product Type, Performance - Potential Analysis
• 6.3. Global Opioids Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
• 6.4. Opioids Market, Sub Segment Analysis
  • 6.4.1. Methadone
  • 6.4.2. Codeine
  • 6.4.3. Fentanyl
  • 6.4.4. Oxycodone
  • 6.4.5. Morphine
  • 6.4.6. Hydrocodone
  • 6.4.7. Others

Chapter 7. Global Opioids Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Opioids Market by Application, Performance - Potential Analysis
• 7.3. Global Opioids Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
• 7.4. Opioids Market, Sub Segment Analysis
  • 7.4.1. Pain Management
  • 7.4.2. Cough Treatment
  • 7.4.3. Diarrhea Treatment

Chapter 8. Global Opioids Market, Regional Analysis

• 8.1. Opioids Market, Regional Market Snapshot
• 8.2. North America Opioids Market
  • 8.2.1. U.S. Opioids Market
    • 8.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Opioids Market
• 8.3. Europe Opioids Market Snapshot
  • 8.3.1. U.K. Opioids Market
  • 8.3.2. Germany Opioids Market
  • 8.3.3. France Opioids Market
  • 8.3.4. Spain Opioids Market
  • 8.3.5. Italy Opioids Market
  • 8.3.6. Rest of Europe Opioids Market
• 8.4. Asia-Pacific Opioids Market Snapshot
  • 8.4.1. China Opioids Market
  • 8.4.2. India Opioids Market
  • 8.4.3. Japan Opioids Market
  • 8.4.4. Australia Opioids Market
  • 8.4.5. South Korea Opioids Market
  • 8.4.6. Rest of Asia Pacific Opioids Market
• 8.5. Latin America Opioids Market Snapshot
  • 8.5.1. Brazil Opioids Market
  • 8.5.2. Mexico Opioids Market
  • 8.5.3. Rest of Latin America Opioids Market
• 8.6. Rest of The World Opioids Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Teva Pharmaceutical Industries Limited
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Purdue Pharma LP
  • 9.2.3. AstraZeneca Plc
  • 9.2.4. C.H. Boehringer Sohn Ag and Co. Kg
  • 9.2.5. Johnson & Johnson, Inc.
  • 9.2.6. Sanofi S.A.
  • 9.2.7. Mallinckrodt Pharmaceuticals
  • 9.2.8. Endo Pharmaceuticals Inc.
  • 9.2.9. Pfizer, Inc.
  • 9.2.10. Sun Pharmaceuticals Industries Limited

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Opioids Market, report scope
• TABLE 2. Global Opioids Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Opioids Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
• TABLE 4. Global Opioids Market estimates & forecasts by Application 2019-2029 (USD Billion)
• TABLE 5. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Opioids Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Opioids Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Opioids Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Opioids Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Opioids Market
• TABLE 70. List of primary sources, used in the study of global Opioids Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Opioids Market, research methodology
• FIG 2. Global Opioids Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Opioids Market, key trends 2021
• FIG 5. Global Opioids Market, growth prospects 2022-2029
• FIG 6. Global Opioids Market, porters 5 force model
• FIG 7. Global Opioids Market, pest analysis
• FIG 8. Global Opioids Market, value chain analysis
• FIG 9. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Opioids Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Opioids Market, regional snapshot 2019 & 2029
• FIG 15. North America Opioids Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Opioids Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Opioids Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Opioids Market 2019 & 2029 (USD Billion)
• FIG 19. Global Opioids Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable